Have you seen an artwork made of live bacteria and genes? Welcome to the world of bioart which has become one of several contemporary art forms that apply scientific methods to explore living systems as artistic subjects.
Bioart ranges from bacterial manipulation to glowing rabbits, cellular sculptures, and -- in the case of Australian-British artist Nina Sellars -- documentation of an ear prosthetic that was implanted onto fellow artist Stelarc's arm.
"Most people do not know that bioart exists but it can enable scientists to produce new ideas and give us opportunities to look differently at problems," said study author Ali K Yetisen from Harvard Medical School.
At the same time, there has been a lot of ethical and safety concerns happening around bioart and artists who wanted to get involved in the past have made mistakes, he added.
Bioart encourages discussions about societal, philosophical and environmental issues.
"It can help enhance public understanding of advances in biotechnology and genetic engineering," added study co-author Ahmet F Coskun from California Institute of Technology.
Joe Davis is an artist who works not only with paints or pastels, but also with genes and bacteria.
Today, Davis is a research affiliate at MIT Biology and "artist-scientist" at the George Church Laboratory at Harvard University.
Davis is working with several members of the Church lab to perform metagenomics analyses of the dust that accumulates at the bottom of money-counting machines.
Another project involves genetically engineering silk worms to spin metallic gold.
In 1986, he collaborated with geneticist Dan Boyd to encode a symbol for life and femininity into an E coli bacterium.
The piece, called Microvenus, was the first artwork to use the tools and techniques of molecular biology.
Since then, bioart has become one of several contemporary art forms -- including reclamation art and nanoart.
"In the era of genetic engineering, bioart will gain new meanings and annotations in social and scientific contexts," Yetisen noted.
A review of the bioart field was published in the journal Trends in Biotechnology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
